Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 50,000 shares at $52.38 ($2.6M) on 2013-12-11, disclosed to the SEC on 2013-12-12.
Open-market sale of $2.6M CLVS by Executive VP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.81 | 25,177 | $1.4M | 51.3% |
| 2 | $54.57 | 700 | $38K | 1.4% |
| 3 | $51.64 | 24,023 | $1.2M | 47.0% |
| 4 | $52.38 | 100 | $5K | 0.2% |
| Total | $52.78 avg | 50,000 | $2.6M | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |